HighTower Advisors’s Theriva Biologics TOVX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q3 | – | Sell |
-4
| Closed | -$8K | – | 2237 |
|
2018
Q2 | $8K | Hold |
4
| – | – | ﹤0.01% | 2093 |
|
2018
Q1 | $12K | Buy |
4
+2
| +100% | +$6K | ﹤0.01% | 2035 |
|
2017
Q4 | $9K | Sell |
2
-3
| -60% | -$13.5K | ﹤0.01% | 2125 |
|
2017
Q3 | $44K | Sell |
5
-2
| -29% | -$17.6K | ﹤0.01% | 2072 |
|
2017
Q2 | $32K | Buy |
7
+2
| +40% | +$9.14K | ﹤0.01% | 2030 |
|
2017
Q1 | $29K | Buy |
5
+1
| +25% | +$5.8K | ﹤0.01% | 1932 |
|
2016
Q4 | $29K | Sell |
4
-1
| -20% | -$7.25K | ﹤0.01% | 1833 |
|
2016
Q3 | $72K | Hold |
5
| – | – | ﹤0.01% | 1763 |
|
2016
Q2 | $76K | Hold |
5
| – | – | ﹤0.01% | 1618 |
|
2016
Q1 | $104K | Hold |
5
| – | – | ﹤0.01% | 1826 |
|
2015
Q4 | $102K | Hold |
5
| – | – | ﹤0.01% | 1835 |
|
2015
Q3 | $97K | Buy |
5
+2
| +67% | +$38.8K | ﹤0.01% | 1735 |
|
2015
Q2 | $78K | Buy |
3
+1
| +50% | +$26K | ﹤0.01% | 1434 |
|
2015
Q1 | $37K | Buy |
+2
| New | +$37K | ﹤0.01% | 1555 |
|